Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03960008 · ClinicalTrials.gov registry record · Phase 3
Stereotactic Body Radiation Therapy (SBRT) vs Trans-Arterial Chemoembolization (TACE) as Bridge to Transplant
A Phase 3 study, sponsored by Lahey Clinic.
- Terminated
- Registry status
- Phase 3
- Development phase
- 9
- Enrollment target
NCT03960008 is a Phase 3 study that was terminated before completion, run by Lahey Clinic. The registered enrollment target is 9 participants.
The verdict
NCT03960008, a Phase 3 study, was terminated before completion, sponsored by Lahey Clinic.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 9 participants
- Enrollment target
Study Summary
This study will compare stereotactic body radiation therapy (SBRT) to trans-arterial chemoembolization (TACE) as a bridging strategy for patients with HCC undergoing liver transplantation. We propose that SBRT will be associated with longer time intervals between initial treatment and the need for retreatment, compared to TACE, as a "bridge" to liver transplantation in subjects with HCC.
Interventions
- RADIATION Stereotactic Body Radiation Therapy (SBRT)
- PROCEDURE Trans-Arterial Chemoembolization (TACE)
- DRUG Doxorubin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2020-03-01 |
| Est. Completion | 2024-02-28 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03960008
The ClinicalTrials.gov registry entry for NCT03960008 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lahey Clinic, which has 43 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Stereotactic Body Radiation Therapy (SBRT) is the first listed.
NCT03960008 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03960008 about?
NCT03960008 is a clinical study titled "Stereotactic Body Radiation Therapy (SBRT) vs Trans-Arterial Chemoembolization (TACE) as Bridge to Transplant". This study will compare stereotactic body radiation therapy (SBRT) to trans-arterial chemoembolization (TACE) as a bridging strategy for patients with HCC undergoing liver transplantation. We propose that SBRT will be associated with longer time intervals between initial treatment and the need for r...
What is the current status of trial NCT03960008?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 9 participants. The study started on 2020-03-01. Estimated completion is 2024-02-28.
What interventions are being tested in trial NCT03960008?
The interventions under investigation include: Stereotactic Body Radiation Therapy (SBRT) (RADIATION), Trans-Arterial Chemoembolization (TACE) (PROCEDURE), Doxorubin (DRUG).
Who is sponsoring clinical trial NCT03960008?
This trial is sponsored by Lahey Clinic, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.